{"DataElement":{"publicId":"6820781","version":"1","preferredName":"Derived Flag Amyloidosis Best Hematologic Response Assessment Outcome of Therapy Performed Date","preferredDefinition":"The day, month and year of the amyloidosis best hematologic response to therapy assessment.","longName":"6820729v1.0:2532012v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6820729","version":"1","preferredName":"Derived Flag Amyloidosis Best Hematologic Response Assessment Outcome of Therapy Performed","preferredDefinition":"An indication that a data element has been derived from one or more data elements._A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands._Having the most positive qualities._An evaluation of the hematologic response of the disease to the therapy._The final result of a determination of the value, significance, or extent of._The result of therapy for a given disease or condition in a patient or group of patients._Executed and carried through to completion.","longName":"6821475v1.0:6820727v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6821475","version":"1","preferredName":"Derived Flag Amyloidosis Best Hematologic Response Assessment","preferredDefinition":"An indication that a data element has been derived from one or more data elements.:A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.:Having the most positive qualities.:An evaluation of the hematologic response of the disease to the therapy.:The final result of a determination of the value, significance, or extent of.","longName":"6821475v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Derived Flag","conceptCode":"C81197","definition":"An indication that a data element has been derived from one or more data elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Amyloidosis","conceptCode":"C2868","definition":"A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematologic Response","conceptCode":"C123622","definition":"An evaluation of the hematologic response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4BC6E0-C255-61A1-E053-F662850AFBF5","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-07-23","modifiedBy":"ONEDATA","dateModified":"2019-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6820727","version":"1","preferredName":"Outcome of Therapy Performed","preferredDefinition":"The result of therapy for a given disease or condition in a patient or group of patients.:Executed and carried through to completion.","longName":"C18919:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E49E8AE-CCEE-778F-E053-F662850A1A43","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-07-22","modifiedBy":"ONEDATA","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E49E8AE-CCFF-778F-E053-F662850A1A43","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-07-22","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2532012","version":"2","preferredName":"Date","preferredDefinition":"The particular day, month and year an event has happened or will happen.","longName":"DATE","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A1B282-BBA9-1DAB-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2009-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-28","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"Created new version associated to different CD and Display Format as part of NMDP Date VD clean up 4/2009. mcooper Corrected def from KM change. AK 3/25/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the date of the amyl","type":"Preferred Question Text","description":"What was the date of the amyloidosis best hematologic response to therapy assessment?","url":null,"context":"NHLBI"},{"name":"Date assessed:","type":"Alternate Question Text","description":"Date assessed:","url":null,"context":"NHLBI"},{"name":"Date assessed:","type":"Application Standard Question Text","description":"Date assessed:","url":null,"context":"NHLBI"},{"name":"Date best hematologic response to line of therapy assessed:","type":"Alternate Question Text","description":"Date best hematologic response to line of therapy assessed:","url":null,"context":"NHLBI"},{"name":"Date hematologic response to line of therapy assessed:","type":"Alternate Question Text","description":"Date hematologic response to line of therapy assessed:","url":null,"context":"NHLBI"},{"name":"Date best response assessed:","type":"Alternate Question Text","description":"Date best response assessed:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4A8C6E-184E-4042-E053-F662850A4BF9","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-07-22","modifiedBy":"MALUMK","dateModified":"2021-02-25","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def. AQT added for 2016r5. 02/25/2021 KMM. AQT added for 2116r5. 02/25/2021 KMM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}